NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/16/2022
Back to search
Official data from USPTO
ACCUDIAG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
02/07/2025
Trademark type
Word
Nice classes
5
Filing date
05/19/2010
Registration date
01/24/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2022
Last transaction
02/07/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/01/2010
First use in commerce
01/01/2011
Drawing code
4
Owner type
03
Owner location
Woodland Hills, CA
Examiner
IN, SUNG
Law office
L30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Diagnostic Automation, Inc.
Diagnostic Automation, Inc.
Representatives
Diagnostic Automation, Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing
Publications
History of USPTO decisions and trademark events.
45 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/16/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/16/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/16/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
01/11/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/24/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/03/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/03/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/02/2018
E815
TEAS SECTION 8 & 15 RECEIVED
01/17/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
01/24/2012
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
12/20/2011
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
12/19/2011
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/14/2011
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/12/2011
INCD
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
08/29/2011
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/08/2011
IUAF
USE AMENDMENT FILED
07/18/2011
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
07/18/2011
EISU
TEAS STATEMENT OF USE RECEIVED
07/18/2011
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
06/07/2011
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
04/22/2011
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
12/16/2010
PUBO
PUBLISHED FOR OPPOSITION
12/07/2010
NPUB
NOTICE OF PUBLICATION
11/17/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/02/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/22/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/22/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/22/2010
ALIE
ASSIGNED TO LIE
10/18/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/08/2010
CNRT
NON-FINAL ACTION MAILED
09/27/2010
CNRT
NON-FINAL ACTION WRITTEN
09/25/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
09/25/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/25/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/22/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/22/2010
ALIE
ASSIGNED TO LIE
09/22/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/16/2010
CNRT
NON-FINAL ACTION MAILED
09/08/2010
CNRT
NON-FINAL ACTION WRITTEN
09/07/2010
DOCK
ASSIGNED TO EXAMINER
09/01/2010
MPMK
NOTICE OF PSEUDO MARK MAILED
05/25/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/24/2010
NWAP
NEW APPLICATION ENTERED
05/22/2010
Continuous trademark protection
Get notified about every new filing that threatens ACCUDIAG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.